Tetralogy of Fallot (ToF) is the most common cyanotic congenital heart disease after 1 year of age. Less than 5% of all patients with uncorrected ToF live beyond the age of 40 years. Prognosis after surgical correction is good with a 32-year survival of 86% of the cases. Predictors of long-term mortality include older age at operation and postoperative right-to-left ventricular peak systolic pressure ratio of 0.5 or higher [1] . Surgery is performed to close ventricular septal defect (VSD) and relieve right ventricular outflow tract obstruction (RVOTO). Adult patients with surgical repair of tetralogy of Fallot in history often develop complications, which include severe pulmonary regurgitation, RVOTO, right ventricular dilation and dysfunction, residual VSD, aortic root dilation with aortic regurgitation, left ventricular dysfunction, endocarditis, atrial and ventricular tachycardia, and sudden cardiac death. We present a case of a female patient with several long-term complications after ToF repair. JRCD 2014; 1 (7): 24-28 
A 40-year-old woman after surgical correction of tetralogy of Fallot (ToF) was admitted to the hospital due to deterioration in exercise tolerance (New York Heart Association functional class III). Correction of ToF was performed in 1974, and surgical closure of residual ventricular septal defect (rVSD) was performed in 2003. A dual-chamber pacemaker was implanted due to sick sinus syndrome associated with paroxysmal atrial fibrillation in 2005. Current treatment included warfarin and metoprolol CR. A physical examination revealed a holosystolic murmur with a thrill at the fourth left intercostal space. The patient's weight was 47 kg, height 159 cm, body mass index 18.6 kg/m 2 , blood pressure 120/80 mm Hg, and heart rate 60 bpm. Regular normal breath sounds were heard and no cyanosis or peripheral edema was observed. The results of routine laboratory tests were within the normal limits except for elevated N-terminal of the prohormone brain natriuretic peptide level (1300 pg/mL; normal value, <125 pg/mL).
A resting electrocardiogram showed sequential atrial and ventricular pacing. Holter monitoring did not reveal cardiac arrhythmias or pacing disturbances. Cardiopulmonary exercise testing showed reduced exercise tolerance (workload of 8.4 metabolic equivalents) and maximal oxygen consumption (15.2 mL/kg/min; normal value, >43.1 mL/kg/min). The values of maximal oxygen consumption were significantly lower compared with the previous measurements (February 2011, 22 mL/kg/min and October 2010, 23 mL/kg/min).
Transthoracic echocardiography revealed numerous abnormalities ( Figure 1. ), and increased pulmonary capillary wedge pressure (16 mm Hg; normal value, <12 mm Hg). An increase in the pulmonary pressure and resistance had been observed since 2007 (Table 1) .
Review of the literature
We described a case of a patient after repair of ToF with severe PR and significant left-to-right shunting through the rVSD. Patients after transannular patch repair of the RVOTO have higher degree of PR compared with patients with subvalvular resection or repair without a patch [2] . PR may be well tolerated for decades before any symptoms develop but, in some patients, it can lead to progressive RV dilatation, onset of TR, and the need for surgery. It is also known as a risk factor for ventricular arrhythmias and sudden cardiac death [3] . Long-term consequences of PR are augmented by coexisting distal pulmonary stenosis and pulmonary arterial hypertension.
CMR is the gold standard to measure the RV function and severity of PR. A regurgitation fraction of 20% to 40% assessed with cardiac MRI is regarded as severe regurgitation [4] . Cardiac MRI cannot be performed in the presence of pacemakers, implantable cardioverter-defibrillators, cochlear implants, and clips for aneurysms in the brain. . Puchalski et al. [6] reported that jet/annulus width exceeding 50% identified patients with severe PR (Table 2) . Timing for pulmonary valve replacement is the most challenging aspect of treatment. Possible beneficial effects should be weighed against the risk of reoperation due to graft dysfunction. Perioperative mortality in patients without heart failure is low (<1%) [7] . Pulmonary valve replacement (PVR) results in improvement in exercise capacity, reduction of the RV size, and decrease in QRS duration [8] . A positive effect of PVR on the RV function is unlikely as soon as the end-diastolic volume exceeds 160 mL/m 2 . Delaying PVRt until the patient becomes symptomatic may increase the risk of high preoperative RV volume [9] . Achieving normalization in the RV volume may improve long-term outcome but there are very limited data on long-term mortality. The development of complications that require a surgery, for example, significant rVSD, severe TR, or pulmonary stenosis may affect the timing of PVR. Another factors include the development of sustained atrial or ventricular arrhythmias, QRS duration, and the presence of myocardial fibrosis on CMR [6, 7] .
There are a number of different pulmonary valve prostheses, such as allografts, xenografts, and mechanical prostheses. Allografts are most common but approximately 50% of the patients will require reoperation due to graft dysfunction 10 years after the surgery [10] . Compared with bioprosthesis, mechanical valve prosthesis shows a lower initial gradient and no substantial increase in the gradient Table 3 . Indications for intervention after repair of tetralogy of Fallot [7] class* level# or regurgitation with time. The advantages are reduced by the risk of valve thrombosis and pannus-related dysfunction, leading to similar reoperation rates [11] . Percutaneous pulmonary valve implantation (PPVI) (Melody, Medtronic, Inc.) may be an option for selected patients with pulmonary homograft dysfunction. Patients after repair of ToF involving valvotomy or valvectomy may not provide secure anchorage to the stented valve. Early after PPVI, a significant decrease in the RV end-diastolic volume is observed [12] . The rate of complications in short-term follow-up is low but the longevity of the valve is unknown [13] . According to the current guidelines, PVR is the standard treatment in symptomatic patients with severe PR. It should be considered in asymptomatic patients with progressive RV dilation or systolic dysfunction, progressive TR, and sustained atrial or ventricular arrhythmias (Table 3 ) [7] .
TR occurs mainly from RV and tricuspid annular dilatation. It results in progressive RV enlargement. Tricuspid valve repair (TVR) is indicated in patients with moderate and severe dilation of the annulus (diameters, >40 mm or >21 mm/m 2 ) undergoing cardiac surgery. TVR using an annuloplasty ring is the preferred surgical approach for TR [14] .
rVSD requiring reintervention after primary surgical repair of ToF is rare [15] . Significant left-to-right shunting through VSD leads to LV volume overload, pulmonary hypertension, resulting in shunt reversal and Eisenmenger's syndrome. Patients with symptoms that can be attributed to left-to-right shunting through VSD who have no severe pulmonary vascular disease as well as patients with VSD and pulmonary arterial hypertension with left-to-right shunt (Qp:Qs >1.5) and pulmonary artery pressure or pulmonary vascular resistance below 2/3 of systemic baseline values or when challenged with vasodilators are candidates for surgery. Moreover, residual VSD closure is recommended if the patient is undergoing pulmonary valve surgery (Table 3,4) .
Patient management and follow-up
Echocardiography and right heart catheterization confirmed that symptoms can be attributed to left-to-right shunting through rVSD, PR ad TR. There are several strong indications for complex surgery according to the European Society of Cardiology guidelines for the management of grown-up congenital heart disease and guidelines on the management of valvular heart disease (Table 3). Our patient was scheduled for complex surgical closure of rVSD, PVR, and TVR.
